Malnutrition promotes prostaglandin over leukotriene production and dysregulates eicosanoid-cytokine crosstalk in activated resident macrophages

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 81, Issue 1, 2009, Pages 41-51

  Anstead, G M ^a,b   Zhang, Q ^b   Melby, P C ^a,b  

^a SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Cytokine; Granulocyte macrophage colony stimulating factor; Interleukin 10; Leukotriene; Macrophage; Malnutrition; Nitric oxide; Prostaglandin; Tumor necrosis factor alpha

Indexed keywords

CALCIUM IONOPHORE; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; ICOSANOID; INTERLEUKIN 10; INTERLEUKIN 6; LEUKOTRIENE DERIVATIVE; LIPOPOLYSACCHARIDE; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FATTY ACID SYNTHESIS; FEMALE; IMMUNE DEFICIENCY; MACROPHAGE ACTIVATION; MALNUTRITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE;

ANIMALS; CALCIMYCIN; CYCLOOXYGENASE INHIBITORS; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; INTERLEUKIN-10; LEUKOTRIENES; LIPOPOLYSACCHARIDES; MACROPHAGES; MALNUTRITION; MICE; MICE, INBRED BALB C; PROSTAGLANDINS; TUMOR NECROSIS FACTOR-ALPHA;

LEISHMANIA DONOVANI; MURINAE; MUS;

EID: 67649424628     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2009.04.011     Document Type: Article

References (74)

1. Pelletier D.L. The potentiating effects of malnutrition on child mortality; epidemiologic and policy implications. Nutr. Rev. 52 (1994) 409-415
2. Anstead G.M., Chandrasekar B., Zhao W., Yang J., Perez L., and Melby P.C. Malnutrition alters the innate immune response and increases early visceralization following Leishmania donovani infection. Infect. Immun. 69 (2001) 4709-4718
3. Anstead G.M., Chandrasekar B., Zhang Q., and Melby P.C. Multinutrient malnutrition dysregulates the resident proinflammatory cytokine network, nuclear factor-κB activation, and nitric oxide production. J. Leukocyte Biol. 74 (2003) 982-991
4. Bonney R.J., and Humes J.L. Physiological and pharmacological regulation of prostaglandin and leukotriene production by macrophages. J. Leukocyte Biol. 35 (1984) 1-10
5. 2. Prostaglandins 24 (1982) 763-774
6. 2 regulate intracellular adhesion molecule-1 expression in interleukin-1β-stimulated human gingival fibroblasts. J. Peridont. Res. 34 (1999) 97-104
7. Hattori Y., and Levi R. Negative inotropic effect of leukotrienes: leukotrienes C4 and D4 inhibit calcium-dependent contractile responses in potassium-depolarized guinea-pig myocardium. J. Pharmacol. Exp. Ther. 230 (1984) 646-651
8. Mexmain S., Cook J., Aldigier J.C., Gualde N., and Rigaud M. Thymocyte cyclic AMP and cyclic GMP response to treatment with metabolites issued from the lipoxygenase pathway. J. Immunol. 135 (1985) 1361-1365
9. Peters-Golden M., Canetti C., Mancuso P., and Coffey M.J. Leukotrienes: underappreciated mediators of innate immune responses. J. Immunol. 173 (2005) 589-594
10. Peplow P.V. Actions of cytokines in relation to arachidonic acid metabolism and eicosanoid production. Prostaglandins Leukot. Essent. Fatty Acids 54 (1996) 303-317
11. de Freitas L.A.R., Mbow M.L., Estay M., Bleyenber J.A., and Titus R.G. Indomethacin treatment slows disease progression and enhances Th1 response in susceptible BALB/c mice infected with Leishmania major. Parasite Immunol. 21 (1999) 273-277
12. 2 and reversal by injection of indomethacin, muramyl dipeptide, or interferon-γ. J. Immunol. 136 (1986) 1820-1827
13. 2 in the immunopathogenesis of experimental pulmonary tuberculosis. Immunology 106 (2002) 257-266
14. Sibley L.D., and Krahenbuhl J.L. Induction of unresponsiveness to gamma interferon in macrophages infected with Mycobacterium leprae. Infect. Immun. 56 (1988) 1912-1919
15. 2 in susceptibility. Parasitol. Res. 85 (1999) 1025-1031
16. Han S.N., Wu D., Ha W.K., Beharka A., Smith D.E., Bender B.S., and Meydani S.N. Vitamin E supplementation increases T helper 1 cytokine production in old mice infected with influenza virus. Immunology 100 (2000) 487-493
17. 2 on amoebic liver abscess formation in hamsters. Prostaglandins 53 (1997) 411-421
18. Mancuso P., Marshal T., Standiford T., and Peters-Golden M. 5-Lipoxygenase reaction products modulate alveolar macrophage phagocytosis of Klebsiella pneumoniae. Infect Immun. 66 (1998) 5140-5146
19. Chen N., Restivo A., and Reiss C.S. Leukotrienes play protective roles early during experimental VSV encephalitis. J. Neuroimmunol. 120 (2001) 94-102
20. Medeiros A.I., Sa-Nunes A., Soares E.G., Peres C.M., Silva C.L., and Faccioli L.H. Blockade of endogenous leukotrienes exacerbates pulmonary histoplasmosis. Infect. Immun. 72 (2004) 1637-1644
21. Secor W.E., Powell M.R., Morgan J., Wynn T.A., and Funk C.D. Mice deficient for 5-lipoxygenase, but not leukocyte-type 12-lipoxygenase, displayed altered immune responses during infection with Schistosoma mansoni. Prostaglandins Other Lipid Mediators 56 (1998) 291-304
22. 4 induces nitric oxide synthesis in Trypanosoma cruzi-infected murine macrophages and mediates resistance to infection. Infect. Immun. 70 (2002) 4247-4253
23. Coffey M.J., Phare S.M., and Peters-Golden M. Role of leukotrienes in killing of Mycobacterium bovis by neutrophils. Prostaglandins Leukot. Essent. Fatty Acids 71 (2004) 185-190
24. Gosselin J., Borgeat P., and Flamand L. Leukotriene B(4) protects latently infected mice against murine cytomegalovirus reactivation following allogeneic transplantation. J. Immunol. 174 (2005) 1587-1593
25. 4 are absent in the cerebrospinal fluid of human immunodeficiency virus type 1-seropositive persons with toxoplasmic encephalitis: evidence for inhibition of 5-lipoxygenase by Toxoplasma gondii. J. Infect. Dis. 179 (1999) 714-716
26. Eskew M.L., Zarkower A., Scheuchenzuber W.J., Burgess J.R., Scholz R.W., Hildenbrandt G., and Reddy C.C. Effects of inadequate vitamin E and/or selenium nutrition on the release of arachidonic acid metabolites in rat alveolar macrophages. Prostaglandins 38 (1989) 79-89
27. Redmond H.P., Shou J., Kelly C.J., Schreiber S., Miller E., Leon P., and Daly J.M. Immunosuppressive mechanisms in protein-calorie malnutrition. Surgery 110 (1991) 311-317
28. Skerrett S., Henderson W., and Martin T. Alveolar macrophage function in rats with severe protein calorie malnutrition; arachidonic acid metabolism, cytokine release, and antimicrobial activity. J. Immunol. 144 (1990) 1052-1061
29. Zijlstra R.T., McCracken B.A., Odle J., Donovan S.M., Gelberg H.B., Petschow B.W., Zuckermann F.A., and Gaskins H.R. Malnutrition modifies pig small intestine inflammatory responses to rotavirus. J. Nutr. 129 (1999) 838-843
30. Cederholm T., Lindgren J.A., and Palmblad J. Impaired leukotriene C4 generation in granulocytes from protein-energy malnourished chronically-ill elderly. J. Intern. Med. 247 (2000) 715-722
31. Bonta I.L., and Ben-Efraim S. Leukotrienes and prostaglandins mutually govern the antitumor potential of macrophages. In: Garaci E., Paoletti R., and Santoro M.G. (Eds). Prostaglandins in Cancer (1987), Springer-Verlag, Berlin/Heidelberg, Germany 193-201
32. Berg D.J., Zhang J., Lauricella D.M., and Moore S.A. IL-10 is a central regulator of cyclooxygenase-2 expression and prostaglandin production. J. Immunol. 166 (2001) 2674-2680
33. 2 and cAMP. J. Immunol. 141 (1988) 587-591
34. Coffey M.J., Phare S.M., Cinti S., Peters-Golden M., and Kazanjian P.H. Granulocyte-macrophage colony-stimulating factor upregulates reduced 5-lipoxygenase metabolism in peripheral blood monocytes and neutrophils in acquired immunodeficiency syndrome. Blood 94 (1999) 3897-3905
35. Mancuso P., Gottschalk A., Phare S.M., Peters-Golden M., Lukas N.W., and Huffnagle G.B. Leptin-deficient mice exhibit impaired host defense in gram-negative pneumonia. J. Immunol. 168 (2002) 4018-4024
36. Rådmark O. Arachidonate 5-lipoxygenase. Prostaglandins Other Lipid Mediators 68-69 (2002) 211-234
37. 2 in the immunopathogenesis of experimental pulmonary tuberculosis. Immunology 106 (2002) 257-266
38. 2 regulates inducible nitric oxide synthase in the murine macrophage cell line J774. Prostaglandins 49 (1995) 105-115
39. Huber M., Beutler B., and Keppler D. Tumor necrosis factor alpha stimulates leukotriene production in vivo. Eur. J. Immunol. 18 (1988) 2085-2088
40. Strassmann G., Patil-Koota V., Finkleman F., Fong M., and Kambayashi T. Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2. J. Exp. Med. 180 (1994) 2365-2370
41. Hill A.D., Naama H., Shou J., Calvano S.E., and Daly J.M. Antimicrobial effects of granulocyte-macrophage colony-stimulating factor in protein-energy malnutrition. Arch. Surg. 130 (1995) 1273-1277 discussion 1277-1278
42. Collins H.L., and Bancroft G.J. Cytokine enhancement of complement-dependent phagocytosis by macrophages: synergy of tumor necrosis factor-α and granulocyte-macrophage colony stimulating factor for phagocytosis of Cryptococcus neoformans. Eur. J. Immunol. 22 (1992) 1447-1454
43. 4 synthesis in rat alveolar macrophages by a nonphospholipase A2 mechanism. J. Immunol. 151 (1993) 2096-2104
44. Smith W.L., Meade E.A., and Dewitt D.L. The interaction of PGH synthase isozymes 1- and -2 with nonsteroidal anti-inflammatory drugs. In: Honn K.V., Marnett L.J., Nigam S., and Dennis E.A. (Eds). Eicosanoid and Other Bioactive Lipids in Cancer, Inflammation, and Radiation Injury 2 (1997), Plenum Press, NY 189-196
45. Gilroy D.W., Tomlinson A., and Willoughby D.A. Differential effects of inhibitors of cycloxygenase (cycloxygenase 1 and cyclooxygenase 2) in acute inflammation. Eur. J. Pharmacol. 355 (1998) 211-217
46. Schade S., Bezugla Y., Kolada A., Kamionka S., Scheibe R., and Dieter P. Diverse coupling of cyclooxygenase 1 and 2 with final prostanoid synthesis in liver macrophages. Biochem. Pharmacol. 64 (2002) 1227-1232
47. Marotta P., Sautebin L., and di Rosa M. Modulation of the induction of nitric oxide synthase by eicosanoids in the murine macrophage cell line J774. Br. J. Pharmacol. 107 (1992) 640-641
48. Yoshikai Y. Roles of prostaglandins and leukotrienes in acute inflammation caused by bacterial infection. Curr. Opin. Infect. Dis. 14 (2001) 257-263
49. Morlion B.J., Torwesten E., Kuhn K.S., Puchstein C., and Fürst P. Cysteinyl-leukotriene generation as a biomarker for survival in the critically ill. Crit. Care Med. 28 (2000) 3655-3658
50. Ménard G., and Bissonnette E.Y. Priming of alveolar macrophages by leukotriene D4. Potentiation of inflammation. Am. J. Respir. Cell Mol. Biol. 23 (2000) 572-577
51. Vaillier D., Daculsi R., Gualde N., and Bezian J.H. Effect of LTB4 on the inhibition of natural cytotoxic activity by PGE2. Cell. Immunol. 139 (1992) 248-258
52. Armstrong R.A. Investigation of the inhibitory effects of PGE2 and selective EP agonists on chemotaxis of human neutrophils. Br. J. Pharmacol. 116 (1995) 2903-2908
53. Ottonello L., Morone M.P., Dapino P., and Dallegri F. Cyclic AMP elevating agents down-regulate the oxidative burst induced by GMCSF in adherent neutrophils. Clin. Exp. Immunol. 101 (1995) 502-506
54. Cox J.P., and Karnovsky M.L. The depression of phagocytosis by exogenous cyclic nucleotides, prostaglandins, and theophylline. J. Cell Biol. 59 (1973) 480-490
55. Scott M.J., Cheadle W.G., Hoth J.J., Peyton J.C., Subbarao K., Shao W.H., and Haribabu B. Leukotriene B4 receptor (BLT-1) modulates neutrophil influx into the peritoneum but not the lung and liver during surgically induced bacterial peritonitis in mice. Clin. Diagn. Lab Immunol. 11 (2004) 936-941
56. Lang S., Lauffer L., Clausen C., Lohr I., Schmitt B., Holzel D., Wollenberg B., Gires O., Kastenbauer E., and Zeidler R. Impaired monocyte function in cancer patients: restoration with a cyclooxygenase-2 inhibitor. FASEB J. 17 (2003) 286-288
57. Friedrich E.B., Tager A.M., Liu E., Pettersson A., Owman C., Munn L., Luster A.D., and Gerszten R.E. Mechanisms of leukotriene B4-triggered monocyte adhesion. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 1761-1767
58. Ruggeri P., Nicocia G., Venza I., Venza M., Valenti A., and Teti D. Polyamine metabolism in prostaglandin E2-treated human T lymphocytes. Immunopharmacol. Immunotoxicol. 22 (2000) 117-129
59. Goodwin J.S., Atluru D., Sierakowski S., and Lianos E.A. Mechanism of action of glucocorticosteroids. Inhibition of T cell proliferation and interleukin 2 production by hydrocortisone is reversed by leukotriene B4. J. Clin. Invest. 77 (1986) 1244-1250
60. Wakasugi N., Virelizier J.-L., Arenzana-Seisdedos F., Rothut B., Mencia Huerta J.-M., Russo-Marie F., and Fiers W. Defective IFN-γ production in the human neonate. II. Role of increased sensitivity to the suppressive effects of prostaglandin E. J. Immunol. 134 (1985) 172-176
61. van der Pouw Kraan T.C., Boeije L.C., Smeenk R.J., Wijdenes J., and Aarden L.A. Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J. Exp. Med. 181 (1995) 775-779
62. Harada Y., Watanabe S., Yssel H., and Arai K. Factors affecting the cytokine production of human T cells stimulated by different modes of activation. J. Allergy Clin. Immunol. 98 (1996) S161-S173
63. Kawano T., Matsuse H., Kondo Y., Machida I., Saeki S., Tomari S., Mitsuta K., Obase Y., Fukushima C., Shimoda T., and Kohno S. Cysteinyl leukotrienes induce nuclear factor kappa B activation and RANTES production in a murine model of asthma. J. Allergy Clin. Immunol. 112 (2003) 369-374
64. 2 suppresses bacterial killing in alveolar macrophages by inhibiting NADPH oxidase. Am. J. Respir. Cell Mol. Biol. 37 (2007) 562-570
65. 4 triggers the invitro and in vivo release of potent antimicrobial agents. J. Immunol. 178 (2007) 8036-8045
66. Mokashi S., Delikatny J., and Orr F.W. Relationship between chemotaxis, chemotactic modulators, and nucleotide levels in cells. Cancer Res. 43 (1983) 1980-1983
67. Goetzl E.J., An S., and Smith W.L. Specificity of expression and effects of eicosanoid mediators in normal physiology and human disease. FASEB J. 9 (1995) 1051-1058
68. Goulet J.L., Snouwaert J.N., Latour A.M., Coffman T.M., and Koller B.H. Altered inflammatory responses in leukotriene-deficient mice. Proc. Natl. Acad. Sci. USA 91 (1994) 12852-12856
69. Levy B.D., Clish C.B., Schmidt B., Gronert K., and Serhan C.N. Lipid mediator class switching during acute inflammation: signals in resolution. Nature Immunol. 2 (2001) 612-619
70. Flamand N., Surette M.E., Picard S., Bourgoin S., and Borget P. Cyclic AMP-mediated inhibition of 5-lipoxygenase translocation and leukotriene biosynthesis in human neutrophils. Mol. Pharmacol. 62 (2002) 250-256
71. Ticconi C., Zicari A., Pontieri G., Saleno A., Mauri A., Piccione E., and Pasetto N. Release of arachidonic acid metabolites by human fetal membranes: interrelationship between leukotriene B4 and prostaglandin E2. Prostaglandins 49 (1995) 197-204
72. 4 production from dendritic cells via an IL-10-dependent mechanism. J. Immunol. 170 (2003) 139-146
73. Mao J.T., Tsu I.-H., Dubinett S.M., Adams B., Sarfian T., Baratelli, Roth M.D., and Serio K.J. Modulation of pulmonary leukotriene production by cyclooxygenase-2 inhibitors and lipopolysaccharide. Clin. Cancer Res. 10 (2004) 6872-6878
74. Ajmone-Cat M.A., Nicolini A., and Minghetti L. Prolonged exposure of microglia to lipopolysaccharide modifies the intracellular signaling pathways and selectively promotes prostaglandin E2 synthesis. J. Neurochem. 87 (2003) 1193-1203